These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31060683)

  • 1. [Femoral-popliteal Arteriosclerosis Obliterans:Review of Evidence-based Studies on Drug-eluting Endovascular Treatment].
    Zhang R; Lai ZC; Liu CW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):256-260. PubMed ID: 31060683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standardize the endovascular treatment for arteriosclerosis obliterans].
    Wang SM; Yao C
    Zhonghua Wai Ke Za Zhi; 2016 Aug; 54(8):564-7. PubMed ID: 27502128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral drug-eluting technology.
    Franzone A; Stabile E; Trimarco B; Esposito G
    Cardiol Clin; 2015 Feb; 33(1):151-62. PubMed ID: 25439337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of drug-coated balloon and common balloon for treatment of superficial femoral artery and popliteal artery arteriosclerosis obliterans: prospective randomized controlled triac].
    Lu JY; Gu JP; Xu WJ; Lou WS; Wang T
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):296-300. PubMed ID: 28377342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percutaneous transluminal angioplasty versus stent implantation for treatment of femoral and popliteal artery lesion resulted from arteriosclerosis obliterans].
    Zhuang JM; Li X; Li TR; Fu J; Luan JY; Wang CM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):160-5. PubMed ID: 26885928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endovascular treatment of critical leg ischemia of arteriosclerosis obliterans].
    Liu CW; Liu B; Ye W; Guan H; Zheng YH; Li YJ; Zeng R; Ni L; Shao J; Tang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Feb; 29(1):33-6. PubMed ID: 17380662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Propionibacterium granulosum bare-metal stent infection after drug-eluting balloon].
    Hernigou J; Gordienco A; Dakhil B; Longuet P; Couffinhal JC; Bagan P
    J Mal Vasc; 2015 Jul; 40(4):259-64. PubMed ID: 26055520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting balloons for treatment of SFA and popliteal disease - A review of current status.
    van den Berg JC
    Eur J Radiol; 2017 Jun; 91():106-115. PubMed ID: 28629556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of endovascular treatment strategies on in-stent restenosis of femoropopliteal artery lesions].
    Fu WG; Yue JN
    Zhonghua Wai Ke Za Zhi; 2016 Aug; 54(8):586-90. PubMed ID: 27502131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds.
    Zeller T; Rastan A; Macharzina R; Beschorner U; Noory E
    Curr Cardiol Rep; 2015 Sep; 17(9):624. PubMed ID: 26238739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endovascular treatment of multilevel arteriosclerosis obliterans of lower extremities].
    Gao Y; Chen S; Yu C; Nie Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Sep; 24(9):1033-6. PubMed ID: 20939467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percutaneous therapy of obliterative disease of the femoropopliteal arteries using stents--2 years' experience].
    Lojík M; Vodnanský P; Krajina A; Masková J; Raupach J; Fridrich J
    Rozhl Chir; 1999 Sep; 78(9):451-6. PubMed ID: 11077874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Eluting Stents in the Superficial Femoral Artery: Real-World Versus Randomized Clinical Trials; You Choose, But Caveat Emptor!
    Klein AJ
    JACC Cardiovasc Interv; 2016 Feb; 9(3):278-280. PubMed ID: 26847119
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
    Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of DES in peripheral in-stent restenosis.
    Zeller T; Macharzina R; Tepe G
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):561-5. PubMed ID: 20671640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving modalities for femoropopliteal interventions.
    Ansel GM; Lumsden AB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim analysis at 6months from the LEG-flow Drug Eluting Balloon for the treatment of femoropopliteal occlusions (LEG-DEB) registry.
    Stabile E; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Goverde P; Losi MA; Giugliano G; Trimarco B; Esposito G
    Int J Cardiol; 2016 Nov; 223():654-655. PubMed ID: 27568985
    [No Abstract]   [Full Text] [Related]  

  • 20. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.